{"gene":"SLC9A1","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":2021,"finding":"Cryo-EM structures of the human NHE1-CHP1 complex were solved in both inward-facing and inhibitor (cariporide)-bound outward-facing conformations, revealing that NHE1 assembles as a symmetrical homodimer and undergoes an elevator-like conformational change during cation exchange. The cariporide binding site was identified. CHP1 differentially associates with the two conformational states of each NHE1 monomer, underlying CHP1 regulation of NHE1 pH-sensitivity.","method":"Cryo-EM structural determination with functional validation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with mechanistic interpretation of conformational states and inhibitor binding site","pmids":["34108458"],"is_preprint":false},{"year":2002,"finding":"NHE1 is predominantly localized in lamellipodia of migrating fibroblasts, where it functions as a plasma membrane anchor for actin filaments through direct binding of ERM (ezrin/radixin/moesin) proteins. Mutations that independently disrupt ERM binding/cytoskeletal anchoring or ion transport each impair cell polarity and migration, demonstrating that both functions are required for directed migration.","method":"Site-directed mutagenesis, wound-healing migration assays, subcellular localization imaging","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal functional dissection with separation-of-function mutations and defined cellular phenotypes; highly cited foundational study","pmids":["12486114"],"is_preprint":false},{"year":2001,"finding":"p38 MAPK directly phosphorylates the C-terminus of NHE1 within a 40-amino-acid region after trophic factor (IL-7 or IL-3) withdrawal. Mass spectrometry identified four phosphorylation sites: Thr717, Ser722, Ser725, and Ser728, leading to NHE1 activation, intracellular alkalinization, and cell death.","method":"In vitro kinase assay, mass spectrometry, dominant-negative kinase expression, pharmacological inhibition","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro phosphorylation assay combined with MS identification of phosphosites and genetic validation","pmids":["11604491"],"is_preprint":false},{"year":2004,"finding":"Under apoptotic stress, NHE1 physically associates with phosphorylated ERM proteins within the cytoskeleton-enriched fraction, recruiting a signaling complex that includes PI3K and Akt, thereby promoting cell survival. ERM-binding-deficient NHE1 abolishes this Akt activation and survival signaling.","method":"Co-immunoprecipitation, dominant-negative constructs, apoptosis assays, NHE1-null cell rescue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with multiple orthogonal approaches and genetic rescue in NHE1-null cells","pmids":["15096511"],"is_preprint":false},{"year":1994,"finding":"NHE1 contains N-linked glycosylation exclusively at Asn75 (first extracellular loop) and O-linked oligosaccharide also restricted to the first extracellular domain. The mature 110-kDa form at the cell surface carries both N- and O-linked sugars, while the 85-kDa ER form carries only N-linked high-mannose oligosaccharide. Glycosylation is not required for transport activity.","method":"Site-directed mutagenesis of N-glycosylation sites, glycosidase treatment, immunoblotting, functional transport assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in expression system with mutagenesis and biochemical validation","pmids":["8068684"],"is_preprint":false},{"year":1994,"finding":"ATP depletion profoundly inhibits NHE1 transport without detectable changes in NHE1 phosphorylation or surface expression, but causes redistribution of NHE1 away from focal accumulations at the plasma membrane. The C-terminal cytosolic domain of NHE1 is required for its ATP dependence. NHE1 co-localizes with F-actin and redistributes when actin is disassembled, indicating interaction with the cytoskeleton.","method":"Truncation mutants, cell-surface biotinylation, immunofluorescence, cytochalasin D treatment, ATP depletion assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — domain mapping with transport assays and imaging; multiple orthogonal methods","pmids":["8132605"],"is_preprint":false},{"year":2014,"finding":"Talin C-terminus binds directly to the moesin FERM domain, recruiting a moesin-NHE1 complex to invadopodia. Silencing talin reduces cytosolic pH at invadopodia and blocks cofilin-dependent actin polymerization, impairing invadopodium stability and matrix degradation.","method":"Direct binding assay (pulldown), siRNA knockdown, live-cell pH imaging, invadopodium assays, in vivo metastasis assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — direct protein-protein interaction demonstrated with functional validation at invadopodia and in vivo metastasis","pmids":["24891603"],"is_preprint":false},{"year":2013,"finding":"The p.Gly305Arg missense mutation in SLC9A1 (NHE1 transmembrane segment 8) causes near-complete de-glycosylation, mis-targeting, and loss of proton-pumping activity of NHE1, resulting in Lichtenstein-Knorr syndrome (ataxia and sensorineural hearing loss).","method":"Homozygosity mapping, whole-exome sequencing, functional transport assay, glycosylation analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic identification combined with direct functional and biochemical characterization of mutant protein","pmids":["25205112"],"is_preprint":false},{"year":2013,"finding":"CHP1 assists in full glycosylation and membrane localization (biosynthetic maturation) of NHE1 required for Purkinje cell axon homeostasis. Truncated CHP1 isoforms are defective in stimulating NHE1 maturation; loss of membrane-localized NHE1 at axon terminals precedes Purkinje cell axon degeneration.","method":"Positional cloning, mouse genetics (vac mutant), subcellular fractionation, immunolocalization, NHE1 null genetic ablation","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis between Chp1 and Nhe1 with direct mechanistic link to NHE1 biosynthetic maturation and localization","pmids":["23904602"],"is_preprint":false},{"year":2006,"finding":"Adenosine A1 receptor stimulation recruits PP2A catalytic subunit to the particulate (NHE1-containing) fraction via Gi proteins. Purified PP2A dephosphorylates a GST-NHE1 fusion protein (aa 625-747) pre-phosphorylated by RSK in vitro. In intact cardiomyocytes, PP2A co-localizes with NHE1 at intercalated discs and its inhibition prevents CPA-mediated attenuation of NHE1 phosphorylation and activity.","method":"In vitro phosphatase assay with purified proteins, co-immunoprecipitation, confocal immunofluorescence, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro dephosphorylation assay with purified PP2A and GST-NHE1, validated in intact cells with multiple methods","pmids":["16707501"],"is_preprint":false},{"year":2010,"finding":"An EPR/structural modeling study confirmed that TM IV and TM XI of NHE1 are in close proximity (~15 Å between spin labels A173C and I461C). This distance decreases at low pH and in the presence of cariporide, consistent with TM IV–TM XI rearrangements during ion translocation and inhibitor binding. Mutation of Arg425 that stabilizes this arrangement causes partial loss of function.","method":"EPR spectroscopy with spin-labeled cysteine mutants, structural modeling (NhaA template), site-directed mutagenesis, functional transport assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — EPR distance measurements combined with mutagenesis and functional validation","pmids":["20974853"],"is_preprint":false},{"year":2011,"finding":"B-Raf associates with the cytosolic regulatory tail (C-terminal 182 aa) of NHE1 in vivo (co-immunoprecipitation from HeLa and HEK cells) and in vitro (purified protein pulldown). The constitutively active B-Raf(V600E) oncogenic mutant increases NHE1 activity and raises resting intracellular pH in melanoma cells; inhibition of B-Raf (sorafenib, PLX4720, or siRNA) abolishes ERK phosphorylation and decreases NHE1 activity.","method":"Co-immunoprecipitation, in vitro pulldown with purified proteins, pharmacological inhibition, siRNA knockdown, intracellular pH measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding established in vitro and in vivo with functional consequence in oncogenic context","pmids":["21345796"],"is_preprint":false},{"year":2011,"finding":"NHE1 is expressed in cardiac mitochondrial membranes. shRNA-mediated knockdown of NHE1 reduced mitochondrial NHE1 by ~60% and significantly reduced Ca2+-induced mitochondrial permeability transition pore (MPTP) opening/swelling by 64%, demonstrating a functional role of mitochondrial NHE1 in MPTP regulation.","method":"Lentiviral shRNA knockdown, mitochondrial fractionation, electron microscopy, immunostaining, mitochondrial swelling assay","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockdown with functional readout, but mitochondrial NHE1 localization is from a single lab","pmids":["21297023"],"is_preprint":false},{"year":2002,"finding":"H2O2 activates NHE-1 activity through ERK1/2-dependent phosphorylation of the NHE-1 carboxyl tail, and this NHE-1 activation mediates ~50% of H2O2-induced intracellular Ca2+ overload in cardiomyocytes.","method":"Intracellular Ca2+ measurement (fura-2), ERK inhibitor (U0126), NHE-1 inhibitor (HOE-642), phosphorylation analysis","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with specific inhibitors and phosphorylation readout; single lab","pmids":["12124207"],"is_preprint":false},{"year":2013,"finding":"EGF promotes complex formation of EGFR with NHE1 via the scaffolding protein NHERF1 (Na+/H+ exchanger regulatory factor 1), engaging EGFR in a negative transregulatory loop that controls EGFR oncogenic signaling duration and stimulates NHE1 activity in pancreatic cancer cells.","method":"Co-immunoprecipitation, 3D growth and invasion assays, NHE1 inhibition, lipid raft fractionation","journal":"Neoplasia","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP-based complex identification with functional correlation; single lab","pmids":["25748234"],"is_preprint":false},{"year":2011,"finding":"Hypoxia activates p90 ribosomal S6 kinase (p90RSK), which phosphorylates NHE-1 at specific sites to increase Na+/H+ exchange rate and intracellular pH, thereby stimulating invadopodium formation and cancer cell invasion.","method":"shRNA depletion of NHE-1, live-cell pH imaging, invadopodium assays, p90RSK inhibition/knockdown, phosphorylation analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological perturbation with functional readout; single lab","pmids":["22216126"],"is_preprint":false},{"year":2007,"finding":"DNA damage in thymocytes upregulates NHE-1 expression, which is necessary and sufficient for subsequent intracellular alkalinization, Bcl-xL deamidation at Asn52/Asn66, and apoptosis. Enforced intracellular alkalinization mimics DNA damage effects.","method":"NHE-1-deficient cell lines, pharmacological inhibition, enforced alkalinization, deamidation assay, apoptosis assays","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with NHE1-null cells and multiple orthogonal mechanistic validations establishing a defined signaling pathway","pmids":["17177603"],"is_preprint":false},{"year":2014,"finding":"NHE1 interacts with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] through its cytosolic domain to promote proximal tubule cell survival. Long-chain acyl-CoA (LC-CoA) metabolites directly interact with the NHE1 cytosolic domain with affinity comparable to PI(4,5)P2 and compete with PI(4,5)P2 for NHE1 binding, disrupting NHE1-PI(4,5)P2 interaction and lowering the apoptotic threshold.","method":"Direct binding assay (LC-CoA vs. PI(4,5)P2 competition), inhibition of LC-CoA catabolism/generation, functional NHE1 activity assay, mouse models of kidney disease","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro binding interaction with affinity measurements combined with in vivo genetic/pharmacological validation","pmids":["24531551"],"is_preprint":false},{"year":2013,"finding":"Phosphorylation of NHE1 at Ser703 by Sgk1 (serum- and glucocorticoid-inducible kinase 1) is required for dexamethasone-stimulated NHE1 activation. In sgk1-knockout mice, dexamethasone fails to increase NHE1 phosphorylation at Ser703 or NHE1 activity.","method":"Sgk1 knockout mice, phospho-specific antibody (P-Ser703), NHE1 activity measurement (BCECF), Sgk1 pharmacological inhibition","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with phosphorylation and functional readout; single lab","pmids":["23860121"],"is_preprint":false},{"year":2010,"finding":"NaV1.5 sodium channels and NHE1 are co-localized in caveolin-1-containing membrane rafts in breast cancer cells. NaV1.5 functionally couples to NHE1 to increase H+ efflux; inhibiting either reduces invasiveness by a similar magnitude with no additive effect when inhibited simultaneously.","method":"Co-localization by immunofluorescence, membrane raft fractionation, Matrigel invasion assay, pharmacological inhibition","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 3 — co-localization with pharmacological co-inhibition epistasis; no direct binding shown","pmids":["21170089"],"is_preprint":false},{"year":2022,"finding":"NHE1 polarizes to the leading edge and SWELL1 to the trailing edge of confined migrating cells, mediating asymmetric water influx and efflux (Osmotic Engine Model) to drive cell protrusion and migration. Optogenetic RhoA activation at the cell front triggers SWELL1 redistribution and migration reversal in a SWELL1-dependent manner. Cdc42 controls NHE1 repolarization. Dual NHE1/SWELL1 knockdown inhibits breast cancer cell extravasation and lung metastasis in vivo.","method":"Live-cell polarization imaging, optogenetics (RhoA, Cdc42), siRNA knockdown, mathematical modeling, in vivo metastasis assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including optogenetics and in vivo validation with defined molecular mechanism","pmids":["36253369"],"is_preprint":false},{"year":1993,"finding":"When NHE1 is transfected into opossum kidney (OK) epithelial cells, it is expressed at the basolateral membrane (whereas endogenous NHE is apical). PKA activation by forskolin inhibits both apical and basolateral NHE activity, while PTH inhibits only apical NHE and phorbol ester (PKC activation) preferentially reduces apical NHE.","method":"Transfection into polarized cells, intracellular pH fluorimetry, pharmacological dissection of regulatory pathways","journal":"Pflugers Archiv","confidence":"Medium","confidence_rationale":"Tier 2 — defined basolateral localization of NHE1 with functional regulatory characterization in polarized epithelia","pmids":["8272382"],"is_preprint":false},{"year":2013,"finding":"Phosphorylation of NHE1 at the p90RSK/14-3-3 site (S703A mutation) is required for maintaining the mesenchymal phenotype of TNBC cells; the S703A mutation converts cells to an epithelial-like morphology with reduced vimentin expression, and markedly reduces migration, invasion, and metastatic potential.","method":"Site-directed mutagenesis of NHE1 regulatory phosphosites, morphological analysis, migration/invasion assays, vimentin expression analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — separation-of-function mutagenesis linking specific phosphosite to defined cellular phenotype; single lab","pmids":["27049728"],"is_preprint":false},{"year":2013,"finding":"Acute sustained intracellular acidosis (SIA) activates NHE1 in kidney cells through an ERK-dependent pathway; in MDCK cells, amino acids Ser771, Ser776, Thr779, and Ser785 in the cytosolic regulatory tail are important for NHE1 phosphorylation and activation after SIA.","method":"Site-directed mutagenesis of NHE1 cytosolic tail, isoform-specific inhibitors, MEK inhibitor (U0126), intracellular pH measurement","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 1 — mutagenesis of specific phosphosites with functional readout; single lab","pmids":["23678047"],"is_preprint":false},{"year":2010,"finding":"Insulin stimulates PI3K-dependent translocation of NHE1 to the cardiomyocyte sarcolemma. Hypoxia, mitochondrial metabolic inhibition, and electrical contraction also translocate NHE1 to the sarcolemma through a PI3K-independent process, providing an additional level of activation beyond intrinsic catalytic regulation.","method":"Immunofluorescence microscopy, cell-surface biotinylation, PI3K inhibition, subcellular fractionation","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence using cell-surface biotinylation and pharmacological dissection; single lab","pmids":["20868366"],"is_preprint":false},{"year":2018,"finding":"Biallelic mutation (p.K19del) in CHP1 causes mutant CHP1 to fail integration into functional protein complexes and aggregate, leading to diminished soluble CHP1 and reduced membrane targeting of NHE1, resulting in autosomal recessive cerebellar ataxia.","method":"Whole-exome sequencing, subcellular fractionation, size-exclusion chromatography, fluorescence microscopy, zebrafish morpholino model with mRNA rescue","journal":"Neurology. Genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods with in vivo zebrafish validation and mRNA rescue demonstrating functional convergence with NHE1","pmids":["29379881"],"is_preprint":false},{"year":1996,"finding":"The NHE-1 promoter contains a functional AP-2 binding site that is critical for promoter activity in neonatal rat cardiomyocytes. Deletion or mutation of this AP-2 site reduces or eliminates promoter activity. Purified AP-2 protein and AP-2-like protein from myocyte nuclear extracts bind the AP-2 site by gel mobility shift assay.","method":"Deletion analysis, mutation of AP-2 site, gel mobility shift assay with purified AP-2 and nuclear extracts","journal":"The American journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 — promoter deletion and mutagenesis with in vitro protein-DNA binding; defined transcriptional mechanism","pmids":["8769760"],"is_preprint":false},{"year":2003,"finding":"An alternatively spliced variant of NHE1 lacking the amiloride binding site is expressed in human reticulocytes and erythrocytes. Transfection of this spliced variant restores amiloride-insensitive, phloretin-sensitive sodium-lithium countertransport (SLC) activity, identifying this alternative splice form as the molecular basis of SLC.","method":"RT-PCR cloning, transfection functional assay, pharmacological profiling","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — functional reconstitution in transfected cells linking alternative splicing to distinct transport activity","pmids":["12765964"],"is_preprint":false},{"year":2008,"finding":"Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling in mice, associated with decreased Rho kinase (ROCK1 and ROCK2) expression and increased p27 expression in NHE1-null mice.","method":"NHE1 knockout mice, hemodynamic measurements, right ventricular weight, histomorphometry, Western blot of downstream signaling","journal":"American journal of respiratory and critical care medicine","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with defined phenotype and downstream pathway analysis; single lab","pmids":["18310478"],"is_preprint":false},{"year":2011,"finding":"Lentiviral shRNA-mediated NHE-1 knockdown in the myocardium abolishes the slow force response (SFR) to myocardial stretch, establishing NHE-1 activation as a key determinant of the contractile SFR (in vitro Anrep effect), even when ERK1/2 phosphorylation is preserved.","method":"Lentiviral shRNA NHE1 knockdown in rat myocardium, intracellular pH measurement, contractile force measurement, ERK1/2 phosphorylation analysis","journal":"Journal of applied physiology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic knockdown with defined functional phenotype; single lab","pmids":["21659487"],"is_preprint":false},{"year":2010,"finding":"NHE1 inhibition suppresses HIF-1α-induced angiogenesis in HUVECs by modulating calpain activity: NHE1 siRNA decreased intracellular pH, reduced calpain-2 (but not calpain-1) expression and calpain activity, and inhibited HIF-1α-driven proliferation, migration, and tube formation. The inhibitory effect was reversed by VEGF and the reversal was abrogated by a calpain inhibitor.","method":"siRNA knockdown of NHE1, calpain activity assay, intracellular pH measurement, Matrigel tube formation assay, epistasis with VEGF and calpain inhibitor","journal":"Microvascular research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KD with defined biochemical mechanism linking NHE1 to calpain-2 regulation; single lab","pmids":["21185840"],"is_preprint":false},{"year":2010,"finding":"NHE-1 associates with the Na-K-ATPase α1-subunit, and ouabain-stimulated Na-K-ATPase activity depends on this NHE-1 interaction. Inhibition or absence of NHE-1 prevents ouabain-mediated stimulation of Na-K-ATPase tyrosine phosphorylation and (86)Rb uptake; re-expression of wild-type NHE-1 in NHE-1-deficient cells restores ouabain regulation.","method":"Co-immunoprecipitation, NHE-1 inhibitor (EIPA), wild-type NHE-1 expression rescue in HK-2 cells, 86Rb uptake, tyrosine phosphorylation assay","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with functional rescue experiment linking NHE1-Na-K-ATPase interaction to regulatory outcome; single lab","pmids":["20427472"],"is_preprint":false}],"current_model":"NHE1 (SLC9A1) is a plasma-membrane homodimeric secondary active transporter that electroneutrally exchanges intracellular H+ for extracellular Na+ via an elevator-like conformational mechanism (TM IV–XI rearrangement); its 12-TM domain mediates ion transport (glycosylated at Asn75) while its ~315-aa cytosolic C-terminal tail serves as a regulatory scaffold—binding ERM proteins to anchor the actin cytoskeleton and recruit PI3K/Akt survival complexes, binding PI(4,5)P2 and competing lipids to sense membrane lipid status, and being phosphorylated by multiple kinases (p38 MAPK at Thr717/Ser722/Ser725/Ser728; ERK/RSK at Ser703; Sgk1 at Ser703; and inhibitory phosphorylation by AKT) to tune ion-transport activity; CHP1 is an obligate binding partner that promotes NHE1 biosynthetic glycosylation, membrane targeting, and pH-sensitivity; through coordinated H+ extrusion and cytoskeletal anchoring, NHE1 regulates intracellular pH, cell volume, migration polarity (polarizing to the leading edge), invadopodium activity, cell survival, cardiac contractility, and axon homeostasis."},"narrative":{"teleology":[{"year":1993,"claim":"Establishing where NHE1 resides in polarized epithelia revealed its basolateral targeting, distinguishing it from apical NHE isoforms and showing it is subject to PKA-mediated inhibition.","evidence":"Transfection of NHE1 into polarized OK cells with intracellular pH fluorimetry and pharmacological dissection","pmids":["8272382"],"confidence":"Medium","gaps":["Basolateral targeting determinants not mapped","PKA phosphorylation site on NHE1 not identified"]},{"year":1994,"claim":"Defining the biochemical features of mature NHE1 showed that Asn75 is the sole N-glycosylation site; glycosylation distinguishes ER from surface forms but is dispensable for transport, while the C-terminal cytosolic domain is required for ATP-dependent regulation and cytoskeletal association.","evidence":"Site-directed mutagenesis of glycosylation sites, glycosidase treatment, truncation mutants, ATP depletion, and cytochalasin D treatment in expression systems","pmids":["8068684","8132605"],"confidence":"High","gaps":["Identity of cytoskeletal binding partners unknown","Mechanism linking ATP to transport regulation undefined"]},{"year":2001,"claim":"Identifying p38 MAPK as a direct NHE1 kinase (Thr717/Ser722/Ser725/Ser728) established a paradigm for stress-responsive phosphoregulation of the exchanger, linking trophic factor withdrawal to NHE1 activation and intracellular alkalinization.","evidence":"In vitro kinase assay, mass spectrometry of phosphosites, dominant-negative p38 expression","pmids":["11604491"],"confidence":"High","gaps":["Relative contribution of individual phosphosites not resolved","Whether p38 phosphorylation changes set-point or Vmax unclear"]},{"year":2002,"claim":"Demonstrating that NHE1 polarizes to lamellipodia and serves dual roles—ion transporter and ERM-mediated actin anchor—with separation-of-function mutants resolved how NHE1 directs cell migration through two independent mechanisms.","evidence":"Site-directed mutagenesis separating ERM binding from transport, wound-healing assays, subcellular imaging in fibroblasts","pmids":["12486114"],"confidence":"High","gaps":["Signal directing NHE1 polarization to leading edge unknown","Whether ERM-binding mutant affects pH gradient at leading edge not tested"]},{"year":2004,"claim":"Revealing that the NHE1-ERM complex recruits PI3K and Akt during apoptotic stress established NHE1 as a survival signaling scaffold beyond its transport function.","evidence":"Co-immunoprecipitation, NHE1-null cell rescue, apoptosis assays with ERM-binding-deficient mutant","pmids":["15096511"],"confidence":"High","gaps":["Direct versus indirect recruitment of PI3K to NHE1-ERM complex not distinguished","Structural basis of the scaffolding interaction unknown"]},{"year":2006,"claim":"Identifying PP2A as a direct NHE1 phosphatase (acting on RSK-phosphorylated residues) recruited via adenosine A1 receptor/Gi signaling provided the first defined dephosphorylation mechanism for NHE1 in cardiomyocytes.","evidence":"In vitro dephosphorylation of GST-NHE1 by purified PP2A, co-IP and confocal co-localization at intercalated discs","pmids":["16707501"],"confidence":"High","gaps":["Specific PP2A holoenzyme (B subunit identity) targeting NHE1 not defined","Whether PP2A regulates p38-dependent phosphosites unknown"]},{"year":2007,"claim":"Showing that DNA damage upregulates NHE1, driving intracellular alkalinization that triggers Bcl-xL deamidation and apoptosis, established a pH-dependent cell death pathway in which NHE1 is the effector.","evidence":"NHE1-deficient cells, pharmacological inhibition, enforced alkalinization, deamidation assay in thymocytes","pmids":["17177603"],"confidence":"High","gaps":["Transcriptional mechanism of NHE1 upregulation after DNA damage not identified","Generalizability beyond thymocytes untested"]},{"year":2010,"claim":"EPR spectroscopy on TM IV and TM XI confirmed their close proximity and pH/inhibitor-dependent rearrangement, providing the first direct biophysical evidence for the conformational change mechanism of NHE1 ion translocation.","evidence":"EPR distance measurements between spin-labeled cysteine pairs, cariporide binding, Arg425 mutagenesis with transport assays","pmids":["20974853"],"confidence":"High","gaps":["Full transport cycle intermediates not captured","No high-resolution structure available at this time"]},{"year":2011,"claim":"Multiple studies converged to show that NHE1 integrates into oncogenic signaling: B-Raf(V600E) directly binds and activates NHE1 to raise intracellular pH in melanoma, while p90RSK phosphorylation of NHE1 drives invadopodium formation under hypoxia, and NHE1 is required for the cardiac slow force response to stretch.","evidence":"Co-IP and in vitro pulldown (B-Raf–NHE1), shRNA knockdown with pH imaging and invadopodium assays, lentiviral NHE1 knockdown in rat myocardium with contractile force measurement","pmids":["21345796","22216126","21659487"],"confidence":"High","gaps":["B-Raf binding site on NHE1 C-tail not mapped to specific residues","Whether stretch-induced NHE1 activation is phosphorylation-dependent or conformational unclear"]},{"year":2013,"claim":"Genetic studies in mice and humans established that CHP1 is required for NHE1 biosynthetic maturation and membrane targeting, and that loss-of-function mutations in either SLC9A1 (p.Gly305Arg) or CHP1 cause cerebellar ataxia with sensorineural hearing loss, defining the NHE1–CHP1 axis as essential for neuronal homeostasis.","evidence":"Homozygosity mapping, whole-exome sequencing, glycosylation analysis (NHE1 G305R), positional cloning of CHP1 vac mutant, genetic epistasis with NHE1 null","pmids":["25205112","23904602","29379881"],"confidence":"High","gaps":["Precise neuronal subtype vulnerability (Purkinje cell specificity) mechanism not fully explained","Whether CHP1 regulates NHE1 transport kinetics independently of maturation not resolved"]},{"year":2014,"claim":"Demonstrating that PI(4,5)P2 binds the NHE1 cytosolic domain and that long-chain acyl-CoA competes for this site linked lipid metabolism to NHE1-dependent cell survival, while talin–moesin–NHE1 complex recruitment to invadopodia established the cytoskeletal scaffolding mechanism for local pH control during invasion.","evidence":"Direct binding/competition assays (PI(4,5)P2 vs. LC-CoA), mouse kidney disease models; talin–moesin pulldown with live-cell pH imaging and in vivo metastasis assay","pmids":["24531551","24891603"],"confidence":"High","gaps":["Structural basis of PI(4,5)P2 binding to NHE1 C-tail unknown","Whether LC-CoA regulation is tissue-specific not determined"]},{"year":2021,"claim":"Cryo-EM structures of the NHE1–CHP1 complex in inward- and outward-facing states resolved the homodimeric elevator mechanism, identified the cariporide binding site, and showed conformational-state-dependent CHP1 association, providing an atomic framework for NHE1 regulation and drug design.","evidence":"Cryo-EM at near-atomic resolution of human NHE1–CHP1 complex in two conformational states with functional validation","pmids":["34108458"],"confidence":"High","gaps":["Structure of the full-length cytosolic regulatory tail not resolved","Lipid-bound and phosphorylated structures not available"]},{"year":2022,"claim":"Establishing that NHE1 and SWELL1 polarize to opposite cell poles to drive osmotic water flux (Osmotic Engine Model) unified NHE1's ion transport and polarity roles into a biophysical mechanism for confined cell migration and metastatic extravasation.","evidence":"Live-cell polarization imaging, optogenetic Cdc42/RhoA activation, dual siRNA knockdown, in vivo metastasis assay","pmids":["36253369"],"confidence":"High","gaps":["Whether the Osmotic Engine Model applies to all confined migration contexts unknown","Mechanism of Cdc42-dependent NHE1 polarization not molecularly defined"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the NHE1 cytosolic tail's multipartner scaffolding (ERM, PI(4,5)P2, kinases), how phosphorylation at distinct sites differentially tunes transport versus scaffolding functions, and whether mitochondrial NHE1 represents a physiologically relevant pool.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of the full cytosolic regulatory domain","Mitochondrial NHE1 localization reported by a single lab awaits independent confirmation","Phosphosite-specific effects on transport kinetics vs. protein interactions not systematically dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,4,5,10,11,27]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[1,3,5,6]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,14]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,4,5,6,20,21,24]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,3,5,6]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,4,5,10,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,11,13,18,23]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[16,17]}],"complexes":["NHE1-CHP1 homodimer","NHE1-ERM-PI3K-Akt survival complex","Talin-moesin-NHE1 invadopodium complex"],"partners":["CHP1","EZR","MSN","RDX","TLN1","BRAF","PPP2CA","NHERF1"],"other_free_text":[]},"mechanistic_narrative":"SLC9A1 encodes NHE1, a ubiquitously expressed plasma membrane Na+/H+ exchanger that functions as a homodimeric secondary active transporter utilizing an elevator-like conformational mechanism to electroneutrally exchange extracellular Na+ for intracellular H+, thereby governing intracellular pH, cell volume, and downstream pH-sensitive signaling [PMID:34108458, PMID:20974853]. Its ~315-residue cytosolic C-terminal tail serves as a multivalent regulatory scaffold: it is phosphorylated by p38 MAPK, ERK/p90RSK, and Sgk1 to tune transport rate, binds PI(4,5)P2 to integrate lipid signaling, and anchors ERM proteins to couple the actin cytoskeleton to the plasma membrane—dual functions (ion transport and cytoskeletal anchoring) that are independently required for cell polarity, directed migration, and invadopodium-driven invasion [PMID:12486114, PMID:11604491, PMID:24891603, PMID:24531551, PMID:22216126]. CHP1 is an obligate biosynthetic partner that promotes NHE1 glycosylation, membrane targeting, and pH sensitivity, and loss of either NHE1 or CHP1 function causes cerebellar ataxia and sensorineural deafness (Lichtenstein–Knorr syndrome) [PMID:34108458, PMID:23904602, PMID:25205112, PMID:29379881]. In cardiomyocytes, NHE1 activation underlies the slow force response to stretch and contributes to oxidative-stress-induced calcium overload, linking its activity to cardiac contractility and pathological remodeling [PMID:21659487, PMID:12124207]."},"prefetch_data":{"uniprot":{"accession":"P19634","full_name":"Sodium/hydrogen exchanger 1","aliases":["APNH","Na(+)/H(+) antiporter, amiloride-sensitive","Na(+)/H(+) exchanger 1","NHE-1","Solute carrier family 9 member 1"],"length_aa":815,"mass_kda":90.8,"function":"Electroneutral Na(+) /H(+) antiporter that extrudes Na(+) in exchange for external protons driven by the inward sodium ion chemical gradient, protecting cells from acidification that occurs from metabolism (PubMed:11350981, PubMed:11532004, PubMed:14680478, PubMed:15035633, PubMed:15677483, PubMed:17073455, PubMed:17493937, PubMed:22020933, PubMed:27650500, PubMed:32130622, PubMed:7110335, PubMed:7603840). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry (By similarity). Plays a key role in maintening intracellular pH neutral and cell volume, and thus is important for cell growth, proliferation, migration and survival (PubMed:12947095, PubMed:15096511, PubMed:22020933, PubMed:8901634). In addition, can transport lithium Li(+) and also functions as a Na(+)/Li(+) antiporter (PubMed:7603840). SLC9A1 also functions in membrane anchoring and organization of scaffolding complexes that coordinate signaling inputs (PubMed:15096511)","subcellular_location":"Cell membrane; Basolateral cell membrane","url":"https://www.uniprot.org/uniprotkb/P19634/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC9A1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC9A1","total_profiled":1310},"omim":[{"mim_id":"618438","title":"SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9","url":"https://www.omim.org/entry/618438"},{"mim_id":"616291","title":"LICHTENSTEIN-KNORR SYNDROME; LIKNS","url":"https://www.omim.org/entry/616291"},{"mim_id":"613410","title":"AUTISM, SUSCEPTIBILITY TO, 16; AUTS16","url":"https://www.omim.org/entry/613410"},{"mim_id":"612738","title":"SOLUTE CARRIER FAMILY 9, MEMBER C1; SLC9C1","url":"https://www.omim.org/entry/612738"},{"mim_id":"611585","title":"TESCALCIN; TESC","url":"https://www.omim.org/entry/611585"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"salivary gland","ntpm":72.1},{"tissue":"stomach 1","ntpm":62.3}],"url":"https://www.proteinatlas.org/search/SLC9A1"},"hgnc":{"alias_symbol":["PPP1R143"],"prev_symbol":["APNH","NHE1","NHE-1"]},"alphafold":{"accession":"P19634","domains":[{"cath_id":"1.20.1530","chopping":"159-507","consensus_level":"high","plddt":87.1578,"start":159,"end":507},{"cath_id":"-","chopping":"525-580","consensus_level":"medium","plddt":69.4277,"start":525,"end":580}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19634","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19634-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19634-F1-predicted_aligned_error_v6.png","plddt_mean":67.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC9A1","jax_strain_url":"https://www.jax.org/strain/search?query=SLC9A1"},"sequence":{"accession":"P19634","fasta_url":"https://rest.uniprot.org/uniprotkb/P19634.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19634/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19634"}},"corpus_meta":[{"pmid":"11807182","id":"PMC_11807182","title":"The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions.","date":"2002","source":"Annual review of pharmacology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/11807182","citation_count":407,"is_preprint":false},{"pmid":"12486114","id":"PMC_12486114","title":"Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12486114","citation_count":370,"is_preprint":false},{"pmid":"21170089","id":"PMC_21170089","title":"Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21170089","citation_count":154,"is_preprint":false},{"pmid":"15096511","id":"PMC_15096511","title":"The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15096511","citation_count":142,"is_preprint":false},{"pmid":"15355855","id":"PMC_15355855","title":"Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes.","date":"2004","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15355855","citation_count":140,"is_preprint":false},{"pmid":"11604491","id":"PMC_11604491","title":"Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11604491","citation_count":137,"is_preprint":false},{"pmid":"23393197","id":"PMC_23393197","title":"Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23393197","citation_count":133,"is_preprint":false},{"pmid":"24195657","id":"PMC_24195657","title":"Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.","date":"2013","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24195657","citation_count":127,"is_preprint":false},{"pmid":"8141271","id":"PMC_8141271","title":"Immunolocalization of anion exchanger AE2 and cation exchanger NHE-1 in distinct adjacent cells of gastric mucosa.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8141271","citation_count":127,"is_preprint":false},{"pmid":"8068684","id":"PMC_8068684","title":"The Na+/H+ exchanger NHE-1 possesses N- and O-linked glycosylation restricted to the first N-terminal extracellular domain.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8068684","citation_count":123,"is_preprint":false},{"pmid":"16734751","id":"PMC_16734751","title":"Role of the Na/H exchanger NHE1 in cell migration.","date":"2006","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16734751","citation_count":117,"is_preprint":false},{"pmid":"18329039","id":"PMC_18329039","title":"The role of NHE-1 in myocardial hypertrophy and remodelling.","date":"2008","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18329039","citation_count":97,"is_preprint":false},{"pmid":"12124207","id":"PMC_12124207","title":"H(2)O(2)-induced Ca(2+) overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway.","date":"2002","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12124207","citation_count":91,"is_preprint":false},{"pmid":"16216978","id":"PMC_16216978","title":"Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.","date":"2005","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/16216978","citation_count":90,"is_preprint":false},{"pmid":"8132605","id":"PMC_8132605","title":"ATP dependence of NHE-1, the ubiquitous isoform of the Na+/H+ antiporter. Analysis of phosphorylation and subcellular localization.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8132605","citation_count":90,"is_preprint":false},{"pmid":"24891603","id":"PMC_24891603","title":"Talin regulates moesin-NHE-1 recruitment to invadopodia and promotes mammary tumor metastasis.","date":"2014","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24891603","citation_count":88,"is_preprint":false},{"pmid":"18328592","id":"PMC_18328592","title":"Protons extruded by NHE1: digestive or glue?","date":"2008","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18328592","citation_count":80,"is_preprint":false},{"pmid":"20886221","id":"PMC_20886221","title":"Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition.","date":"2010","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20886221","citation_count":78,"is_preprint":false},{"pmid":"34108458","id":"PMC_34108458","title":"Structure and mechanism of the human NHE1-CHP1 complex.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34108458","citation_count":72,"is_preprint":false},{"pmid":"22216126","id":"PMC_22216126","title":"Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK).","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22216126","citation_count":71,"is_preprint":false},{"pmid":"25748234","id":"PMC_25748234","title":"A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy.","date":"2015","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25748234","citation_count":70,"is_preprint":false},{"pmid":"29363134","id":"PMC_29363134","title":"The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29363134","citation_count":64,"is_preprint":false},{"pmid":"17177603","id":"PMC_17177603","title":"DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.","date":"2007","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/17177603","citation_count":61,"is_preprint":false},{"pmid":"18310478","id":"PMC_18310478","title":"Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling.","date":"2008","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18310478","citation_count":61,"is_preprint":false},{"pmid":"35217813","id":"PMC_35217813","title":"Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling.","date":"2022","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/35217813","citation_count":60,"is_preprint":false},{"pmid":"20427472","id":"PMC_20427472","title":"Ouabain stimulates Na-K-ATPase through a sodium/hydrogen exchanger-1 (NHE-1)-dependent mechanism in human kidney proximal tubule cells.","date":"2010","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20427472","citation_count":59,"is_preprint":false},{"pmid":"16707501","id":"PMC_16707501","title":"A novel role for protein phosphatase 2A in receptor-mediated regulation of the cardiac sarcolemmal Na+/H+ exchanger NHE1.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16707501","citation_count":59,"is_preprint":false},{"pmid":"36253369","id":"PMC_36253369","title":"Polarized NHE1 and SWELL1 regulate migration direction, efficiency and metastasis.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36253369","citation_count":58,"is_preprint":false},{"pmid":"19887620","id":"PMC_19887620","title":"Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19887620","citation_count":55,"is_preprint":false},{"pmid":"19318234","id":"PMC_19318234","title":"Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19318234","citation_count":53,"is_preprint":false},{"pmid":"22387884","id":"PMC_22387884","title":"Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22387884","citation_count":51,"is_preprint":false},{"pmid":"24531551","id":"PMC_24531551","title":"Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24531551","citation_count":50,"is_preprint":false},{"pmid":"27049728","id":"PMC_27049728","title":"Na+/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27049728","citation_count":50,"is_preprint":false},{"pmid":"33061571","id":"PMC_33061571","title":"Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33061571","citation_count":49,"is_preprint":false},{"pmid":"29895196","id":"PMC_29895196","title":"The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells.","date":"2018","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/29895196","citation_count":49,"is_preprint":false},{"pmid":"12440691","id":"PMC_12440691","title":"Structure and function of the NHE1 isoform of the Na+/H+ exchanger.","date":"2002","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/12440691","citation_count":48,"is_preprint":false},{"pmid":"23860121","id":"PMC_23860121","title":"Sgk1-dependent stimulation of cardiac Na+/H+ exchanger Nhe1 by dexamethasone.","date":"2013","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23860121","citation_count":48,"is_preprint":false},{"pmid":"16185280","id":"PMC_16185280","title":"Extracellular pH Controls NHE1 expression in epidermis and keratinocytes: implications for barrier repair.","date":"2005","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16185280","citation_count":46,"is_preprint":false},{"pmid":"32242030","id":"PMC_32242030","title":"Pyrazine ring-based Na+/H+ exchanger (NHE) inhibitors potently inhibit cancer cell growth in 3D culture, independent of NHE1.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32242030","citation_count":45,"is_preprint":false},{"pmid":"17321481","id":"PMC_17321481","title":"Regulation of mitogen-activated protein kinase pathways by the plasma membrane Na+/H+ exchanger, NHE1.","date":"2006","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/17321481","citation_count":44,"is_preprint":false},{"pmid":"30849956","id":"PMC_30849956","title":"Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30849956","citation_count":43,"is_preprint":false},{"pmid":"25205112","id":"PMC_25205112","title":"Mutation of SLC9A1, encoding the major Na⁺/H⁺ exchanger, causes ataxia-deafness Lichtenstein-Knorr syndrome.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25205112","citation_count":41,"is_preprint":false},{"pmid":"28055960","id":"PMC_28055960","title":"Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28055960","citation_count":40,"is_preprint":false},{"pmid":"26304834","id":"PMC_26304834","title":"Physiological Functions and Regulation of the Na+/H+ Exchanger [NHE1] in Renal Tubule Epithelial Cells.","date":"2015","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/26304834","citation_count":40,"is_preprint":false},{"pmid":"17943310","id":"PMC_17943310","title":"NHE1, NHE2, and NHE4 contribute to regulation of cell pH in T84 colon cancer cells.","date":"2007","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17943310","citation_count":39,"is_preprint":false},{"pmid":"8833201","id":"PMC_8833201","title":"Cellular distribution and regulation of NHE-1 isoform of the NA-H exchanger in the avian osteoclast.","date":"1996","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/8833201","citation_count":39,"is_preprint":false},{"pmid":"20974853","id":"PMC_20974853","title":"Structural modeling and electron paramagnetic resonance spectroscopy of the human Na+/H+ exchanger isoform 1, NHE1.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20974853","citation_count":39,"is_preprint":false},{"pmid":"11259449","id":"PMC_11259449","title":"Immunolocalization of anion exchanger AE2, Na(+)/H(+) exchangers NHE1 and NHE4, and vacuolar type H(+)-ATPase in rat pancreas.","date":"2001","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/11259449","citation_count":39,"is_preprint":false},{"pmid":"15229867","id":"PMC_15229867","title":"Comparative biology of the ubiquitous Na+/H+ exchanger, NHE1: lessons from erythrocytes.","date":"2004","source":"Journal of experimental zoology. Part A, Comparative experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15229867","citation_count":37,"is_preprint":false},{"pmid":"21297023","id":"PMC_21297023","title":"Silencing of cardiac mitochondrial NHE1 prevents mitochondrial permeability transition pore opening.","date":"2011","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21297023","citation_count":37,"is_preprint":false},{"pmid":"17982256","id":"PMC_17982256","title":"The Na+/H+ exchanger, NHE1, differentially regulates mitogen-activated protein kinase subfamilies after osmotic shrinkage in Ehrlich Lettre Ascites cells.","date":"2007","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17982256","citation_count":37,"is_preprint":false},{"pmid":"19179646","id":"PMC_19179646","title":"Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart.","date":"2009","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/19179646","citation_count":36,"is_preprint":false},{"pmid":"21185840","id":"PMC_21185840","title":"Suppression of NHE1 by small interfering RNA inhibits HIF-1α-induced angiogenesis in vitro via modulation of calpain activity.","date":"2010","source":"Microvascular research","url":"https://pubmed.ncbi.nlm.nih.gov/21185840","citation_count":36,"is_preprint":false},{"pmid":"19958503","id":"PMC_19958503","title":"Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human.","date":"2009","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19958503","citation_count":36,"is_preprint":false},{"pmid":"26679950","id":"PMC_26679950","title":"Na (+)/H (+)exchange in the tumour microenvironment: does NHE1 drive breast cancer carcinogenesis?","date":"2015","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26679950","citation_count":35,"is_preprint":false},{"pmid":"16495213","id":"PMC_16495213","title":"Increased NHE1 expression is associated with serum deprivation-induced differentiation in immortalized rat proximal tubule cells.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16495213","citation_count":35,"is_preprint":false},{"pmid":"9580638","id":"PMC_9580638","title":"Colitis-induced changes in the expression of the Na+/H+ exchanger isoform NHE-1.","date":"1998","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/9580638","citation_count":35,"is_preprint":false},{"pmid":"19111554","id":"PMC_19111554","title":"Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.","date":"2008","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19111554","citation_count":35,"is_preprint":false},{"pmid":"25240639","id":"PMC_25240639","title":"Physiological cardiac hypertrophy: critical role of AKT in the prevention of NHE-1 hyperactivity.","date":"2014","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25240639","citation_count":34,"is_preprint":false},{"pmid":"23253131","id":"PMC_23253131","title":"Inside out: targeting NHE1 as an intracellular and extracellular regulator of cancer progression.","date":"2013","source":"Chemical biology & drug design","url":"https://pubmed.ncbi.nlm.nih.gov/23253131","citation_count":33,"is_preprint":false},{"pmid":"21345796","id":"PMC_21345796","title":"B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21345796","citation_count":33,"is_preprint":false},{"pmid":"17614935","id":"PMC_17614935","title":"Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure.","date":"2007","source":"Cardiovascular drug reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17614935","citation_count":31,"is_preprint":false},{"pmid":"11181403","id":"PMC_11181403","title":"alpha(1)-Adrenergic receptors activate NHE1 and NHE3 through distinct signaling pathways in epithelial cells.","date":"2001","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11181403","citation_count":31,"is_preprint":false},{"pmid":"8272382","id":"PMC_8272382","title":"Na/H exchange activities in NHE1-transfected OK-cells: cell polarity and regulation.","date":"1993","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8272382","citation_count":31,"is_preprint":false},{"pmid":"7511337","id":"PMC_7511337","title":"Enhanced Na(+)-H+ exchanger activity and NHE-1 mRNA levels in human lymphocytes during metabolic acidosis.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7511337","citation_count":31,"is_preprint":false},{"pmid":"8944647","id":"PMC_8944647","title":"Biosynthesis and cell surface delivery of the NHE1 isoform of Na+/H+ exchanger in A6 cells.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8944647","citation_count":31,"is_preprint":false},{"pmid":"39046464","id":"PMC_39046464","title":"Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.","date":"2024","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/39046464","citation_count":30,"is_preprint":false},{"pmid":"30089233","id":"PMC_30089233","title":"The role of CD44, hyaluronan and NHE1 in cardiac remodeling.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30089233","citation_count":30,"is_preprint":false},{"pmid":"30018422","id":"PMC_30018422","title":"A novel SLC9A1 mutation causes cerebellar ataxia.","date":"2018","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30018422","citation_count":29,"is_preprint":false},{"pmid":"33344518","id":"PMC_33344518","title":"Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts.","date":"2020","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33344518","citation_count":29,"is_preprint":false},{"pmid":"18263712","id":"PMC_18263712","title":"Role of NHE1 in calcium signaling and cell proliferation in human CNS pericytes.","date":"2008","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18263712","citation_count":28,"is_preprint":false},{"pmid":"31595734","id":"PMC_31595734","title":"Cardioprotective role of IGF-1 in the hypertrophied myocardium of the spontaneously hypertensive rats: A key effect on NHE-1 activity.","date":"2018","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31595734","citation_count":28,"is_preprint":false},{"pmid":"10663560","id":"PMC_10663560","title":"Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene.","date":"2000","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10663560","citation_count":28,"is_preprint":false},{"pmid":"23678047","id":"PMC_23678047","title":"Acidosis-mediated regulation of the NHE1 isoform of the Na⁺/H⁺ exchanger in renal cells.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23678047","citation_count":28,"is_preprint":false},{"pmid":"24173371","id":"PMC_24173371","title":"Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility.","date":"2013","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24173371","citation_count":27,"is_preprint":false},{"pmid":"20868366","id":"PMC_20868366","title":"Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte responses to insulin and energy-status signalling.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20868366","citation_count":27,"is_preprint":false},{"pmid":"21870055","id":"PMC_21870055","title":"In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy.","date":"2011","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21870055","citation_count":27,"is_preprint":false},{"pmid":"25680790","id":"PMC_25680790","title":"Na+-H+ exchanger-1 (NHE1) regulation in kidney proximal tubule.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/25680790","citation_count":26,"is_preprint":false},{"pmid":"20679416","id":"PMC_20679416","title":"A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway.","date":"2010","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/20679416","citation_count":26,"is_preprint":false},{"pmid":"10329949","id":"PMC_10329949","title":"Cloning and expression of the Na+/H+ exchanger from Amphiuma RBCs: resemblance to mammalian NHE1.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10329949","citation_count":26,"is_preprint":false},{"pmid":"22803959","id":"PMC_22803959","title":"Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat.","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22803959","citation_count":26,"is_preprint":false},{"pmid":"21659487","id":"PMC_21659487","title":"Silencing of NHE-1 blunts the slow force response to myocardial stretch.","date":"2011","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/21659487","citation_count":25,"is_preprint":false},{"pmid":"8769760","id":"PMC_8769760","title":"Regulation of NHE-1 promoter in mammalian myocardium.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8769760","citation_count":25,"is_preprint":false},{"pmid":"7557121","id":"PMC_7557121","title":"NHE-1 isoform of the Na+/H+ antiport is expressed in the rat and rabbit esophagus.","date":"1995","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/7557121","citation_count":25,"is_preprint":false},{"pmid":"23904602","id":"PMC_23904602","title":"CHP1-mediated NHE1 biosynthetic maturation is required for Purkinje cell axon homeostasis.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23904602","citation_count":25,"is_preprint":false},{"pmid":"32587517","id":"PMC_32587517","title":"KV11.1 Potassium Channel and the Na+/H+ Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32587517","citation_count":24,"is_preprint":false},{"pmid":"24557342","id":"PMC_24557342","title":"High glucose concentration stimulates NHE-1 activity in distal nephron cells: the role of the Mek/Erk1/2/p90RSK and p38MAPK signaling pathways.","date":"2014","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24557342","citation_count":24,"is_preprint":false},{"pmid":"30592266","id":"PMC_30592266","title":"Normobaric oxygen inhibits AQP4 and NHE1 expression in experimental focal ischemic stroke.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30592266","citation_count":23,"is_preprint":false},{"pmid":"18365869","id":"PMC_18365869","title":"KCNA1 and TRPC6 ion channels and NHE1 exchanger operate the biological outcome of HGF/scatter factor in renal tubular cells.","date":"2007","source":"Growth factors (Chur, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/18365869","citation_count":23,"is_preprint":false},{"pmid":"10971224","id":"PMC_10971224","title":"Expression of the Na(+)/H(+) exchanger isoform NHE1 in rat skeletal muscle and effect of training.","date":"2000","source":"Acta physiologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/10971224","citation_count":23,"is_preprint":false},{"pmid":"25080524","id":"PMC_25080524","title":"RhoA and MAPK signal transduction pathways regulate NHE1-dependent proximal tubule cell apoptosis after mechanical stretch.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25080524","citation_count":22,"is_preprint":false},{"pmid":"12765964","id":"PMC_12765964","title":"Alternative splicing of NHE-1 mediates Na-Li countertransport and associates with activity rate.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12765964","citation_count":21,"is_preprint":false},{"pmid":"18661333","id":"PMC_18661333","title":"NHE-1: a molecular target for signalling and cell matrix interactions.","date":"2008","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/18661333","citation_count":21,"is_preprint":false},{"pmid":"21455270","id":"PMC_21455270","title":"Structural analysis of the Na+/H+ exchanger isoform 1 (NHE1) using the divide and conquer approach.","date":"2011","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/21455270","citation_count":20,"is_preprint":false},{"pmid":"29379881","id":"PMC_29379881","title":"Biallelic CHP1 mutation causes human autosomal recessive ataxia by impairing NHE1 function.","date":"2018","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29379881","citation_count":20,"is_preprint":false},{"pmid":"32703317","id":"PMC_32703317","title":"Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia.","date":"2020","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32703317","citation_count":19,"is_preprint":false},{"pmid":"33717270","id":"PMC_33717270","title":"Advances in research on the regulatory mechanism of NHE1 in tumors.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33717270","citation_count":19,"is_preprint":false},{"pmid":"31015514","id":"PMC_31015514","title":"The Na+/H+-Exchanger NHE1 Regulates Extra- and Intracellular pH and Nimodipine-sensitive [Ca2+]i in the Suprachiasmatic Nucleus.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31015514","citation_count":18,"is_preprint":false},{"pmid":"27629415","id":"PMC_27629415","title":"Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27629415","citation_count":18,"is_preprint":false},{"pmid":"21856903","id":"PMC_21856903","title":"NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts.","date":"2011","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21856903","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54088,"output_tokens":7869,"usd":0.14015},"stage2":{"model":"claude-opus-4-6","input_tokens":11601,"output_tokens":3694,"usd":0.225532},"total_usd":0.365682,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structures of the human NHE1-CHP1 complex were solved in both inward-facing and inhibitor (cariporide)-bound outward-facing conformations, revealing that NHE1 assembles as a symmetrical homodimer and undergoes an elevator-like conformational change during cation exchange. The cariporide binding site was identified. CHP1 differentially associates with the two conformational states of each NHE1 monomer, underlying CHP1 regulation of NHE1 pH-sensitivity.\",\n      \"method\": \"Cryo-EM structural determination with functional validation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with mechanistic interpretation of conformational states and inhibitor binding site\",\n      \"pmids\": [\"34108458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NHE1 is predominantly localized in lamellipodia of migrating fibroblasts, where it functions as a plasma membrane anchor for actin filaments through direct binding of ERM (ezrin/radixin/moesin) proteins. Mutations that independently disrupt ERM binding/cytoskeletal anchoring or ion transport each impair cell polarity and migration, demonstrating that both functions are required for directed migration.\",\n      \"method\": \"Site-directed mutagenesis, wound-healing migration assays, subcellular localization imaging\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal functional dissection with separation-of-function mutations and defined cellular phenotypes; highly cited foundational study\",\n      \"pmids\": [\"12486114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"p38 MAPK directly phosphorylates the C-terminus of NHE1 within a 40-amino-acid region after trophic factor (IL-7 or IL-3) withdrawal. Mass spectrometry identified four phosphorylation sites: Thr717, Ser722, Ser725, and Ser728, leading to NHE1 activation, intracellular alkalinization, and cell death.\",\n      \"method\": \"In vitro kinase assay, mass spectrometry, dominant-negative kinase expression, pharmacological inhibition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro phosphorylation assay combined with MS identification of phosphosites and genetic validation\",\n      \"pmids\": [\"11604491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Under apoptotic stress, NHE1 physically associates with phosphorylated ERM proteins within the cytoskeleton-enriched fraction, recruiting a signaling complex that includes PI3K and Akt, thereby promoting cell survival. ERM-binding-deficient NHE1 abolishes this Akt activation and survival signaling.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative constructs, apoptosis assays, NHE1-null cell rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with multiple orthogonal approaches and genetic rescue in NHE1-null cells\",\n      \"pmids\": [\"15096511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"NHE1 contains N-linked glycosylation exclusively at Asn75 (first extracellular loop) and O-linked oligosaccharide also restricted to the first extracellular domain. The mature 110-kDa form at the cell surface carries both N- and O-linked sugars, while the 85-kDa ER form carries only N-linked high-mannose oligosaccharide. Glycosylation is not required for transport activity.\",\n      \"method\": \"Site-directed mutagenesis of N-glycosylation sites, glycosidase treatment, immunoblotting, functional transport assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in expression system with mutagenesis and biochemical validation\",\n      \"pmids\": [\"8068684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ATP depletion profoundly inhibits NHE1 transport without detectable changes in NHE1 phosphorylation or surface expression, but causes redistribution of NHE1 away from focal accumulations at the plasma membrane. The C-terminal cytosolic domain of NHE1 is required for its ATP dependence. NHE1 co-localizes with F-actin and redistributes when actin is disassembled, indicating interaction with the cytoskeleton.\",\n      \"method\": \"Truncation mutants, cell-surface biotinylation, immunofluorescence, cytochalasin D treatment, ATP depletion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain mapping with transport assays and imaging; multiple orthogonal methods\",\n      \"pmids\": [\"8132605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Talin C-terminus binds directly to the moesin FERM domain, recruiting a moesin-NHE1 complex to invadopodia. Silencing talin reduces cytosolic pH at invadopodia and blocks cofilin-dependent actin polymerization, impairing invadopodium stability and matrix degradation.\",\n      \"method\": \"Direct binding assay (pulldown), siRNA knockdown, live-cell pH imaging, invadopodium assays, in vivo metastasis assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct protein-protein interaction demonstrated with functional validation at invadopodia and in vivo metastasis\",\n      \"pmids\": [\"24891603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The p.Gly305Arg missense mutation in SLC9A1 (NHE1 transmembrane segment 8) causes near-complete de-glycosylation, mis-targeting, and loss of proton-pumping activity of NHE1, resulting in Lichtenstein-Knorr syndrome (ataxia and sensorineural hearing loss).\",\n      \"method\": \"Homozygosity mapping, whole-exome sequencing, functional transport assay, glycosylation analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic identification combined with direct functional and biochemical characterization of mutant protein\",\n      \"pmids\": [\"25205112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CHP1 assists in full glycosylation and membrane localization (biosynthetic maturation) of NHE1 required for Purkinje cell axon homeostasis. Truncated CHP1 isoforms are defective in stimulating NHE1 maturation; loss of membrane-localized NHE1 at axon terminals precedes Purkinje cell axon degeneration.\",\n      \"method\": \"Positional cloning, mouse genetics (vac mutant), subcellular fractionation, immunolocalization, NHE1 null genetic ablation\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis between Chp1 and Nhe1 with direct mechanistic link to NHE1 biosynthetic maturation and localization\",\n      \"pmids\": [\"23904602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Adenosine A1 receptor stimulation recruits PP2A catalytic subunit to the particulate (NHE1-containing) fraction via Gi proteins. Purified PP2A dephosphorylates a GST-NHE1 fusion protein (aa 625-747) pre-phosphorylated by RSK in vitro. In intact cardiomyocytes, PP2A co-localizes with NHE1 at intercalated discs and its inhibition prevents CPA-mediated attenuation of NHE1 phosphorylation and activity.\",\n      \"method\": \"In vitro phosphatase assay with purified proteins, co-immunoprecipitation, confocal immunofluorescence, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro dephosphorylation assay with purified PP2A and GST-NHE1, validated in intact cells with multiple methods\",\n      \"pmids\": [\"16707501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"An EPR/structural modeling study confirmed that TM IV and TM XI of NHE1 are in close proximity (~15 Å between spin labels A173C and I461C). This distance decreases at low pH and in the presence of cariporide, consistent with TM IV–TM XI rearrangements during ion translocation and inhibitor binding. Mutation of Arg425 that stabilizes this arrangement causes partial loss of function.\",\n      \"method\": \"EPR spectroscopy with spin-labeled cysteine mutants, structural modeling (NhaA template), site-directed mutagenesis, functional transport assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — EPR distance measurements combined with mutagenesis and functional validation\",\n      \"pmids\": [\"20974853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"B-Raf associates with the cytosolic regulatory tail (C-terminal 182 aa) of NHE1 in vivo (co-immunoprecipitation from HeLa and HEK cells) and in vitro (purified protein pulldown). The constitutively active B-Raf(V600E) oncogenic mutant increases NHE1 activity and raises resting intracellular pH in melanoma cells; inhibition of B-Raf (sorafenib, PLX4720, or siRNA) abolishes ERK phosphorylation and decreases NHE1 activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro pulldown with purified proteins, pharmacological inhibition, siRNA knockdown, intracellular pH measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding established in vitro and in vivo with functional consequence in oncogenic context\",\n      \"pmids\": [\"21345796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NHE1 is expressed in cardiac mitochondrial membranes. shRNA-mediated knockdown of NHE1 reduced mitochondrial NHE1 by ~60% and significantly reduced Ca2+-induced mitochondrial permeability transition pore (MPTP) opening/swelling by 64%, demonstrating a functional role of mitochondrial NHE1 in MPTP regulation.\",\n      \"method\": \"Lentiviral shRNA knockdown, mitochondrial fractionation, electron microscopy, immunostaining, mitochondrial swelling assay\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockdown with functional readout, but mitochondrial NHE1 localization is from a single lab\",\n      \"pmids\": [\"21297023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"H2O2 activates NHE-1 activity through ERK1/2-dependent phosphorylation of the NHE-1 carboxyl tail, and this NHE-1 activation mediates ~50% of H2O2-induced intracellular Ca2+ overload in cardiomyocytes.\",\n      \"method\": \"Intracellular Ca2+ measurement (fura-2), ERK inhibitor (U0126), NHE-1 inhibitor (HOE-642), phosphorylation analysis\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with specific inhibitors and phosphorylation readout; single lab\",\n      \"pmids\": [\"12124207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EGF promotes complex formation of EGFR with NHE1 via the scaffolding protein NHERF1 (Na+/H+ exchanger regulatory factor 1), engaging EGFR in a negative transregulatory loop that controls EGFR oncogenic signaling duration and stimulates NHE1 activity in pancreatic cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, 3D growth and invasion assays, NHE1 inhibition, lipid raft fractionation\",\n      \"journal\": \"Neoplasia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP-based complex identification with functional correlation; single lab\",\n      \"pmids\": [\"25748234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hypoxia activates p90 ribosomal S6 kinase (p90RSK), which phosphorylates NHE-1 at specific sites to increase Na+/H+ exchange rate and intracellular pH, thereby stimulating invadopodium formation and cancer cell invasion.\",\n      \"method\": \"shRNA depletion of NHE-1, live-cell pH imaging, invadopodium assays, p90RSK inhibition/knockdown, phosphorylation analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological perturbation with functional readout; single lab\",\n      \"pmids\": [\"22216126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DNA damage in thymocytes upregulates NHE-1 expression, which is necessary and sufficient for subsequent intracellular alkalinization, Bcl-xL deamidation at Asn52/Asn66, and apoptosis. Enforced intracellular alkalinization mimics DNA damage effects.\",\n      \"method\": \"NHE-1-deficient cell lines, pharmacological inhibition, enforced alkalinization, deamidation assay, apoptosis assays\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with NHE1-null cells and multiple orthogonal mechanistic validations establishing a defined signaling pathway\",\n      \"pmids\": [\"17177603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NHE1 interacts with phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] through its cytosolic domain to promote proximal tubule cell survival. Long-chain acyl-CoA (LC-CoA) metabolites directly interact with the NHE1 cytosolic domain with affinity comparable to PI(4,5)P2 and compete with PI(4,5)P2 for NHE1 binding, disrupting NHE1-PI(4,5)P2 interaction and lowering the apoptotic threshold.\",\n      \"method\": \"Direct binding assay (LC-CoA vs. PI(4,5)P2 competition), inhibition of LC-CoA catabolism/generation, functional NHE1 activity assay, mouse models of kidney disease\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro binding interaction with affinity measurements combined with in vivo genetic/pharmacological validation\",\n      \"pmids\": [\"24531551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phosphorylation of NHE1 at Ser703 by Sgk1 (serum- and glucocorticoid-inducible kinase 1) is required for dexamethasone-stimulated NHE1 activation. In sgk1-knockout mice, dexamethasone fails to increase NHE1 phosphorylation at Ser703 or NHE1 activity.\",\n      \"method\": \"Sgk1 knockout mice, phospho-specific antibody (P-Ser703), NHE1 activity measurement (BCECF), Sgk1 pharmacological inhibition\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with phosphorylation and functional readout; single lab\",\n      \"pmids\": [\"23860121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NaV1.5 sodium channels and NHE1 are co-localized in caveolin-1-containing membrane rafts in breast cancer cells. NaV1.5 functionally couples to NHE1 to increase H+ efflux; inhibiting either reduces invasiveness by a similar magnitude with no additive effect when inhibited simultaneously.\",\n      \"method\": \"Co-localization by immunofluorescence, membrane raft fractionation, Matrigel invasion assay, pharmacological inhibition\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-localization with pharmacological co-inhibition epistasis; no direct binding shown\",\n      \"pmids\": [\"21170089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NHE1 polarizes to the leading edge and SWELL1 to the trailing edge of confined migrating cells, mediating asymmetric water influx and efflux (Osmotic Engine Model) to drive cell protrusion and migration. Optogenetic RhoA activation at the cell front triggers SWELL1 redistribution and migration reversal in a SWELL1-dependent manner. Cdc42 controls NHE1 repolarization. Dual NHE1/SWELL1 knockdown inhibits breast cancer cell extravasation and lung metastasis in vivo.\",\n      \"method\": \"Live-cell polarization imaging, optogenetics (RhoA, Cdc42), siRNA knockdown, mathematical modeling, in vivo metastasis assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including optogenetics and in vivo validation with defined molecular mechanism\",\n      \"pmids\": [\"36253369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"When NHE1 is transfected into opossum kidney (OK) epithelial cells, it is expressed at the basolateral membrane (whereas endogenous NHE is apical). PKA activation by forskolin inhibits both apical and basolateral NHE activity, while PTH inhibits only apical NHE and phorbol ester (PKC activation) preferentially reduces apical NHE.\",\n      \"method\": \"Transfection into polarized cells, intracellular pH fluorimetry, pharmacological dissection of regulatory pathways\",\n      \"journal\": \"Pflugers Archiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined basolateral localization of NHE1 with functional regulatory characterization in polarized epithelia\",\n      \"pmids\": [\"8272382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phosphorylation of NHE1 at the p90RSK/14-3-3 site (S703A mutation) is required for maintaining the mesenchymal phenotype of TNBC cells; the S703A mutation converts cells to an epithelial-like morphology with reduced vimentin expression, and markedly reduces migration, invasion, and metastatic potential.\",\n      \"method\": \"Site-directed mutagenesis of NHE1 regulatory phosphosites, morphological analysis, migration/invasion assays, vimentin expression analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — separation-of-function mutagenesis linking specific phosphosite to defined cellular phenotype; single lab\",\n      \"pmids\": [\"27049728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Acute sustained intracellular acidosis (SIA) activates NHE1 in kidney cells through an ERK-dependent pathway; in MDCK cells, amino acids Ser771, Ser776, Thr779, and Ser785 in the cytosolic regulatory tail are important for NHE1 phosphorylation and activation after SIA.\",\n      \"method\": \"Site-directed mutagenesis of NHE1 cytosolic tail, isoform-specific inhibitors, MEK inhibitor (U0126), intracellular pH measurement\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of specific phosphosites with functional readout; single lab\",\n      \"pmids\": [\"23678047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Insulin stimulates PI3K-dependent translocation of NHE1 to the cardiomyocyte sarcolemma. Hypoxia, mitochondrial metabolic inhibition, and electrical contraction also translocate NHE1 to the sarcolemma through a PI3K-independent process, providing an additional level of activation beyond intrinsic catalytic regulation.\",\n      \"method\": \"Immunofluorescence microscopy, cell-surface biotinylation, PI3K inhibition, subcellular fractionation\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence using cell-surface biotinylation and pharmacological dissection; single lab\",\n      \"pmids\": [\"20868366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Biallelic mutation (p.K19del) in CHP1 causes mutant CHP1 to fail integration into functional protein complexes and aggregate, leading to diminished soluble CHP1 and reduced membrane targeting of NHE1, resulting in autosomal recessive cerebellar ataxia.\",\n      \"method\": \"Whole-exome sequencing, subcellular fractionation, size-exclusion chromatography, fluorescence microscopy, zebrafish morpholino model with mRNA rescue\",\n      \"journal\": \"Neurology. Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods with in vivo zebrafish validation and mRNA rescue demonstrating functional convergence with NHE1\",\n      \"pmids\": [\"29379881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The NHE-1 promoter contains a functional AP-2 binding site that is critical for promoter activity in neonatal rat cardiomyocytes. Deletion or mutation of this AP-2 site reduces or eliminates promoter activity. Purified AP-2 protein and AP-2-like protein from myocyte nuclear extracts bind the AP-2 site by gel mobility shift assay.\",\n      \"method\": \"Deletion analysis, mutation of AP-2 site, gel mobility shift assay with purified AP-2 and nuclear extracts\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter deletion and mutagenesis with in vitro protein-DNA binding; defined transcriptional mechanism\",\n      \"pmids\": [\"8769760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"An alternatively spliced variant of NHE1 lacking the amiloride binding site is expressed in human reticulocytes and erythrocytes. Transfection of this spliced variant restores amiloride-insensitive, phloretin-sensitive sodium-lithium countertransport (SLC) activity, identifying this alternative splice form as the molecular basis of SLC.\",\n      \"method\": \"RT-PCR cloning, transfection functional assay, pharmacological profiling\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution in transfected cells linking alternative splicing to distinct transport activity\",\n      \"pmids\": [\"12765964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling in mice, associated with decreased Rho kinase (ROCK1 and ROCK2) expression and increased p27 expression in NHE1-null mice.\",\n      \"method\": \"NHE1 knockout mice, hemodynamic measurements, right ventricular weight, histomorphometry, Western blot of downstream signaling\",\n      \"journal\": \"American journal of respiratory and critical care medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined phenotype and downstream pathway analysis; single lab\",\n      \"pmids\": [\"18310478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Lentiviral shRNA-mediated NHE-1 knockdown in the myocardium abolishes the slow force response (SFR) to myocardial stretch, establishing NHE-1 activation as a key determinant of the contractile SFR (in vitro Anrep effect), even when ERK1/2 phosphorylation is preserved.\",\n      \"method\": \"Lentiviral shRNA NHE1 knockdown in rat myocardium, intracellular pH measurement, contractile force measurement, ERK1/2 phosphorylation analysis\",\n      \"journal\": \"Journal of applied physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic knockdown with defined functional phenotype; single lab\",\n      \"pmids\": [\"21659487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NHE1 inhibition suppresses HIF-1α-induced angiogenesis in HUVECs by modulating calpain activity: NHE1 siRNA decreased intracellular pH, reduced calpain-2 (but not calpain-1) expression and calpain activity, and inhibited HIF-1α-driven proliferation, migration, and tube formation. The inhibitory effect was reversed by VEGF and the reversal was abrogated by a calpain inhibitor.\",\n      \"method\": \"siRNA knockdown of NHE1, calpain activity assay, intracellular pH measurement, Matrigel tube formation assay, epistasis with VEGF and calpain inhibitor\",\n      \"journal\": \"Microvascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KD with defined biochemical mechanism linking NHE1 to calpain-2 regulation; single lab\",\n      \"pmids\": [\"21185840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NHE-1 associates with the Na-K-ATPase α1-subunit, and ouabain-stimulated Na-K-ATPase activity depends on this NHE-1 interaction. Inhibition or absence of NHE-1 prevents ouabain-mediated stimulation of Na-K-ATPase tyrosine phosphorylation and (86)Rb uptake; re-expression of wild-type NHE-1 in NHE-1-deficient cells restores ouabain regulation.\",\n      \"method\": \"Co-immunoprecipitation, NHE-1 inhibitor (EIPA), wild-type NHE-1 expression rescue in HK-2 cells, 86Rb uptake, tyrosine phosphorylation assay\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with functional rescue experiment linking NHE1-Na-K-ATPase interaction to regulatory outcome; single lab\",\n      \"pmids\": [\"20427472\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NHE1 (SLC9A1) is a plasma-membrane homodimeric secondary active transporter that electroneutrally exchanges intracellular H+ for extracellular Na+ via an elevator-like conformational mechanism (TM IV–XI rearrangement); its 12-TM domain mediates ion transport (glycosylated at Asn75) while its ~315-aa cytosolic C-terminal tail serves as a regulatory scaffold—binding ERM proteins to anchor the actin cytoskeleton and recruit PI3K/Akt survival complexes, binding PI(4,5)P2 and competing lipids to sense membrane lipid status, and being phosphorylated by multiple kinases (p38 MAPK at Thr717/Ser722/Ser725/Ser728; ERK/RSK at Ser703; Sgk1 at Ser703; and inhibitory phosphorylation by AKT) to tune ion-transport activity; CHP1 is an obligate binding partner that promotes NHE1 biosynthetic glycosylation, membrane targeting, and pH-sensitivity; through coordinated H+ extrusion and cytoskeletal anchoring, NHE1 regulates intracellular pH, cell volume, migration polarity (polarizing to the leading edge), invadopodium activity, cell survival, cardiac contractility, and axon homeostasis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLC9A1 encodes NHE1, a ubiquitously expressed plasma membrane Na+/H+ exchanger that functions as a homodimeric secondary active transporter utilizing an elevator-like conformational mechanism to electroneutrally exchange extracellular Na+ for intracellular H+, thereby governing intracellular pH, cell volume, and downstream pH-sensitive signaling [PMID:34108458, PMID:20974853]. Its ~315-residue cytosolic C-terminal tail serves as a multivalent regulatory scaffold: it is phosphorylated by p38 MAPK, ERK/p90RSK, and Sgk1 to tune transport rate, binds PI(4,5)P2 to integrate lipid signaling, and anchors ERM proteins to couple the actin cytoskeleton to the plasma membrane—dual functions (ion transport and cytoskeletal anchoring) that are independently required for cell polarity, directed migration, and invadopodium-driven invasion [PMID:12486114, PMID:11604491, PMID:24891603, PMID:24531551, PMID:22216126]. CHP1 is an obligate biosynthetic partner that promotes NHE1 glycosylation, membrane targeting, and pH sensitivity, and loss of either NHE1 or CHP1 function causes cerebellar ataxia and sensorineural deafness (Lichtenstein–Knorr syndrome) [PMID:34108458, PMID:23904602, PMID:25205112, PMID:29379881]. In cardiomyocytes, NHE1 activation underlies the slow force response to stretch and contributes to oxidative-stress-induced calcium overload, linking its activity to cardiac contractility and pathological remodeling [PMID:21659487, PMID:12124207].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing where NHE1 resides in polarized epithelia revealed its basolateral targeting, distinguishing it from apical NHE isoforms and showing it is subject to PKA-mediated inhibition.\",\n      \"evidence\": \"Transfection of NHE1 into polarized OK cells with intracellular pH fluorimetry and pharmacological dissection\",\n      \"pmids\": [\"8272382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basolateral targeting determinants not mapped\", \"PKA phosphorylation site on NHE1 not identified\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defining the biochemical features of mature NHE1 showed that Asn75 is the sole N-glycosylation site; glycosylation distinguishes ER from surface forms but is dispensable for transport, while the C-terminal cytosolic domain is required for ATP-dependent regulation and cytoskeletal association.\",\n      \"evidence\": \"Site-directed mutagenesis of glycosylation sites, glycosidase treatment, truncation mutants, ATP depletion, and cytochalasin D treatment in expression systems\",\n      \"pmids\": [\"8068684\", \"8132605\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of cytoskeletal binding partners unknown\", \"Mechanism linking ATP to transport regulation undefined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying p38 MAPK as a direct NHE1 kinase (Thr717/Ser722/Ser725/Ser728) established a paradigm for stress-responsive phosphoregulation of the exchanger, linking trophic factor withdrawal to NHE1 activation and intracellular alkalinization.\",\n      \"evidence\": \"In vitro kinase assay, mass spectrometry of phosphosites, dominant-negative p38 expression\",\n      \"pmids\": [\"11604491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of individual phosphosites not resolved\", \"Whether p38 phosphorylation changes set-point or Vmax unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that NHE1 polarizes to lamellipodia and serves dual roles—ion transporter and ERM-mediated actin anchor—with separation-of-function mutants resolved how NHE1 directs cell migration through two independent mechanisms.\",\n      \"evidence\": \"Site-directed mutagenesis separating ERM binding from transport, wound-healing assays, subcellular imaging in fibroblasts\",\n      \"pmids\": [\"12486114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal directing NHE1 polarization to leading edge unknown\", \"Whether ERM-binding mutant affects pH gradient at leading edge not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealing that the NHE1-ERM complex recruits PI3K and Akt during apoptotic stress established NHE1 as a survival signaling scaffold beyond its transport function.\",\n      \"evidence\": \"Co-immunoprecipitation, NHE1-null cell rescue, apoptosis assays with ERM-binding-deficient mutant\",\n      \"pmids\": [\"15096511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect recruitment of PI3K to NHE1-ERM complex not distinguished\", \"Structural basis of the scaffolding interaction unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying PP2A as a direct NHE1 phosphatase (acting on RSK-phosphorylated residues) recruited via adenosine A1 receptor/Gi signaling provided the first defined dephosphorylation mechanism for NHE1 in cardiomyocytes.\",\n      \"evidence\": \"In vitro dephosphorylation of GST-NHE1 by purified PP2A, co-IP and confocal co-localization at intercalated discs\",\n      \"pmids\": [\"16707501\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific PP2A holoenzyme (B subunit identity) targeting NHE1 not defined\", \"Whether PP2A regulates p38-dependent phosphosites unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing that DNA damage upregulates NHE1, driving intracellular alkalinization that triggers Bcl-xL deamidation and apoptosis, established a pH-dependent cell death pathway in which NHE1 is the effector.\",\n      \"evidence\": \"NHE1-deficient cells, pharmacological inhibition, enforced alkalinization, deamidation assay in thymocytes\",\n      \"pmids\": [\"17177603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional mechanism of NHE1 upregulation after DNA damage not identified\", \"Generalizability beyond thymocytes untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"EPR spectroscopy on TM IV and TM XI confirmed their close proximity and pH/inhibitor-dependent rearrangement, providing the first direct biophysical evidence for the conformational change mechanism of NHE1 ion translocation.\",\n      \"evidence\": \"EPR distance measurements between spin-labeled cysteine pairs, cariporide binding, Arg425 mutagenesis with transport assays\",\n      \"pmids\": [\"20974853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full transport cycle intermediates not captured\", \"No high-resolution structure available at this time\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple studies converged to show that NHE1 integrates into oncogenic signaling: B-Raf(V600E) directly binds and activates NHE1 to raise intracellular pH in melanoma, while p90RSK phosphorylation of NHE1 drives invadopodium formation under hypoxia, and NHE1 is required for the cardiac slow force response to stretch.\",\n      \"evidence\": \"Co-IP and in vitro pulldown (B-Raf–NHE1), shRNA knockdown with pH imaging and invadopodium assays, lentiviral NHE1 knockdown in rat myocardium with contractile force measurement\",\n      \"pmids\": [\"21345796\", \"22216126\", \"21659487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"B-Raf binding site on NHE1 C-tail not mapped to specific residues\", \"Whether stretch-induced NHE1 activation is phosphorylation-dependent or conformational unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genetic studies in mice and humans established that CHP1 is required for NHE1 biosynthetic maturation and membrane targeting, and that loss-of-function mutations in either SLC9A1 (p.Gly305Arg) or CHP1 cause cerebellar ataxia with sensorineural hearing loss, defining the NHE1–CHP1 axis as essential for neuronal homeostasis.\",\n      \"evidence\": \"Homozygosity mapping, whole-exome sequencing, glycosylation analysis (NHE1 G305R), positional cloning of CHP1 vac mutant, genetic epistasis with NHE1 null\",\n      \"pmids\": [\"25205112\", \"23904602\", \"29379881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise neuronal subtype vulnerability (Purkinje cell specificity) mechanism not fully explained\", \"Whether CHP1 regulates NHE1 transport kinetics independently of maturation not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that PI(4,5)P2 binds the NHE1 cytosolic domain and that long-chain acyl-CoA competes for this site linked lipid metabolism to NHE1-dependent cell survival, while talin–moesin–NHE1 complex recruitment to invadopodia established the cytoskeletal scaffolding mechanism for local pH control during invasion.\",\n      \"evidence\": \"Direct binding/competition assays (PI(4,5)P2 vs. LC-CoA), mouse kidney disease models; talin–moesin pulldown with live-cell pH imaging and in vivo metastasis assay\",\n      \"pmids\": [\"24531551\", \"24891603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PI(4,5)P2 binding to NHE1 C-tail unknown\", \"Whether LC-CoA regulation is tissue-specific not determined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Cryo-EM structures of the NHE1–CHP1 complex in inward- and outward-facing states resolved the homodimeric elevator mechanism, identified the cariporide binding site, and showed conformational-state-dependent CHP1 association, providing an atomic framework for NHE1 regulation and drug design.\",\n      \"evidence\": \"Cryo-EM at near-atomic resolution of human NHE1–CHP1 complex in two conformational states with functional validation\",\n      \"pmids\": [\"34108458\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full-length cytosolic regulatory tail not resolved\", \"Lipid-bound and phosphorylated structures not available\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Establishing that NHE1 and SWELL1 polarize to opposite cell poles to drive osmotic water flux (Osmotic Engine Model) unified NHE1's ion transport and polarity roles into a biophysical mechanism for confined cell migration and metastatic extravasation.\",\n      \"evidence\": \"Live-cell polarization imaging, optogenetic Cdc42/RhoA activation, dual siRNA knockdown, in vivo metastasis assay\",\n      \"pmids\": [\"36253369\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the Osmotic Engine Model applies to all confined migration contexts unknown\", \"Mechanism of Cdc42-dependent NHE1 polarization not molecularly defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the NHE1 cytosolic tail's multipartner scaffolding (ERM, PI(4,5)P2, kinases), how phosphorylation at distinct sites differentially tunes transport versus scaffolding functions, and whether mitochondrial NHE1 represents a physiologically relevant pool.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of the full cytosolic regulatory domain\", \"Mitochondrial NHE1 localization reported by a single lab awaits independent confirmation\", \"Phosphosite-specific effects on transport kinetics vs. protein interactions not systematically dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 4, 5, 10, 11, 27]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [1, 3, 5, 6]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 14]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 4, 5, 6, 20, 21, 24]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 3, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 4, 5, 10, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 11, 13, 18, 23]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [16, 17]}\n    ],\n    \"complexes\": [\n      \"NHE1-CHP1 homodimer\",\n      \"NHE1-ERM-PI3K-Akt survival complex\",\n      \"Talin-moesin-NHE1 invadopodium complex\"\n    ],\n    \"partners\": [\n      \"CHP1\",\n      \"EZR\",\n      \"MSN\",\n      \"RDX\",\n      \"TLN1\",\n      \"BRAF\",\n      \"PPP2CA\",\n      \"NHERF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}